Impact of the Depression Epidemic: Family & Community

EntheogeniX Biosciences gets going

Psilocybin, ibogaine, and many other psychedelic substances have yielded remarkable early signals…

Mental health in a time of COVID-19

Whether you’re on lockdown or just practicing social distancing, chances are you’re beginning to…

Let’s take a closer look at psilocybin

“Magic mushrooms” have officially entered the mainstream. Proponents in the media now…

Terence Kelly appointed CEO of ATAI platform company Perception Neuroscience

ATAI Life Sciences Announces Joint Venture with DemeRx to Develop Ibogaine For Opioid Use Disorder

GABA Therapeutics commences phase I study of Etifoxine

ATAI’s Chief Scientific Officer addresses the future of psychiatric drug development at ISAD19

Origins of the Youth Mental Health Crisis

With so many factors influencing the development of adolescents and young adults, there…

Inequality: An overlooked contributor to mental health disorders (part 1)